ArticleJournal for immunotherapy of cancer2025

Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study.

Lajos Pusztai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.